<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01204957</url>
  </required_header>
  <id_info>
    <org_study_id>USCIRB#060701</org_study_id>
    <nct_id>NCT01204957</nct_id>
  </id_info>
  <brief_title>Brown Seaweed as a Breast Cancer Preventive</brief_title>
  <official_title>Brown Seaweed as a Breast Cancer Preventive</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Susan G. Komen Breast Cancer Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of South Carolina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Japanese postmenopausal women in Japan have about one ninth the rate of American
      postmenopausal women. Rates of breast cancer double even after just ten years among Japanese
      women who migrate to the US. Diet is thought to be an important factor, and the investigators
      were interested in whether dietary seaweed, with and without soy supplements, could influence
      known biomarkers of breast cancer risk in American women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      33 healthy postmenopausal women were randomized to 6 wk seaweed then 1 wk seaweed plus soy or
      6 wk placebo then 1 wk placebo plus soy. Blood and urine samples were collected at the end of
      each treatment period and analyzed for estrogen, homocysteine, antioxidants, insulin-like
      growth factors and thyroid hormones. Urine was analyzed for phytoestrogens and iodine.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 1998</start_date>
  <completion_date type="Actual">March 1999</completion_date>
  <primary_completion_date type="Actual">March 1999</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Thyroid hormones affected by dietary seaweed and soy supplements</measure>
    <time_frame>14 weeks</time_frame>
    <description>6 wk seaweed followed by 1 wk seaweed plus soy; Or 6 wk placebo followed by 1 wk soy 3 wk washout period then crossover to alternate arm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum estrogen and urinary phytoestrogen concentrations affected by seaweed and soy</measure>
    <time_frame>14 wks</time_frame>
    <description>6 wk seaweed then 1 wk seaweed plus soy; OR 6 wk placebo then 1 wk soy 3 wk washout period, then crossover to alternate arm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum antioxidant and homocysteine concentrations associated with seaweed and soy</measure>
    <time_frame>14 wks</time_frame>
    <description>6 wks seaweed followed by 1 wk seaweed plus soy OR 6 wk placebo followed by 1 wk soy 3 wk washout period, then crossover to alternate arm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum IGF-1 and IGFBP3 changes associated with seaweed and soy supplementation</measure>
    <time_frame>14 wk</time_frame>
    <description>6 wk seaweed then 1 wk seaweed plus soy OR 6 wk placebo then 1 wk soy plus placebo 3 wk washout then crossover to alternate arm</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Arm 1 Seaweed and Soy Protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm 1 5 g/d Seaweed for 6 wk, then 5 g/d Seaweed and Soy Protein for 1 wk</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2 Placebo and soy protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm 2 5 g/d Placebo for 6 wk, then 5 g/d Placebo and Soy Protein for 1 wk</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Seaweed and Soy Protein</intervention_name>
    <description>5 g/d Seaweed for 6 wks, followed by 5 g/d Seaweed + Soy Protein for 1 wk</description>
    <arm_group_label>Arm 1 Seaweed and Soy Protein</arm_group_label>
    <other_name>Solae Soy Food Ingredient Powder (AB1.2 HG 20CA 29)</other_name>
    <other_name>Alaria esculenta</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo and Soy Protein</intervention_name>
    <description>5 g/d Placebo for 6 wks, followed by 5 g/d Placebo + Soy Protein for 1 wk</description>
    <arm_group_label>Arm 2 Placebo and soy protein</arm_group_label>
    <other_name>Solae Nutritious Food Ingredient Powder (AB1.2 HG 20CA 29)</other_name>
    <other_name>Maltrin M100 maltodextrin (Grain Processing)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Postmenopausal (self-reported cessation of menstruation 1 y prior to enrollment)

          -  If breast cancer survivor, all therapy completed at least 6 months prior to enrollment

          -  Agreed to eat their normal diet, avoiding seaweeds and phytoestrogen-rich foods,

          -  Restricting alcoholic intake to #2 drinks (24 g alcohol)/wk -Continuing habitual
             intake of vitamins, supplements, and medications during the study. -

        Exclusion Criteria:

          -  No allergies to seaweed, soy, shellfish, or iodine

          -  No current use of tobacco;

          -  No thyroid dysfunction or treatment within the previous 5 y;

          -  Negative thyroid peroxidase antibodies as determined by screening;

          -  No hormone replacement therapy or for breast cancer survivors, no chemotherapy or
             radiation treatments within the preceding 6 mo

          -  No history of cancer (other than breast cancer)

          -  No current gastrointestinal disorders or diabetes; omnivorous eating habits, including
             meat and dairy products at least twice/wk

          -  No oral antibiotics, iodine containing medications, or corticosteroids treatment
             within the previous 3 mo.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jane Teas, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>University of South Carolina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Massachusetts</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Teas J, Hurley TG, Hebert JR, Franke AA, Sepkovic DW, Kurzer MS. Dietary seaweed modifies estrogen and phytoestrogen metabolism in healthy postmenopausal women. J Nutr. 2009 May;139(5):939-44. doi: 10.3945/jn.108.100834. Epub 2009 Mar 25. Erratum in: J Nutr. 2009 Sep;139(9):1779.</citation>
    <PMID>19321575</PMID>
  </results_reference>
  <results_reference>
    <citation>Teas J, Braverman LE, Kurzer MS, Pino S, Hurley TG, Hebert JR. Seaweed and soy: companion foods in Asian cuisine and their effects on thyroid function in American women. J Med Food. 2007 Mar;10(1):90-100.</citation>
    <PMID>17472472</PMID>
  </results_reference>
  <results_reference>
    <citation>Teas J, Pino S, Critchley A, Braverman LE. Variability of iodine content in common commercially available edible seaweeds. Thyroid. 2004 Oct;14(10):836-41.</citation>
    <PMID>15588380</PMID>
  </results_reference>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2010</study_first_submitted>
  <study_first_submitted_qc>September 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2010</study_first_posted>
  <last_update_submitted>April 2, 2015</last_update_submitted>
  <last_update_submitted_qc>April 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of South Carolina</investigator_affiliation>
    <investigator_full_name>Jane Teas</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Homocysteine</keyword>
  <keyword>Insulin-like growth factor</keyword>
  <keyword>Insulin-like growth factor binding protein</keyword>
  <keyword>Serum estrogen</keyword>
  <keyword>Urinary phytoestrogens</keyword>
  <keyword>Thyroid hormones</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

